Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1903 1
2005 1
2007 1
2008 5
2009 3
2010 3
2011 9
2012 16
2013 5
2014 20
2015 3
2016 5
2017 14
2018 7
2019 11
2020 10
2021 9
2022 17
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 23144450

128 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials.
Sundy JS, Baraf HS, Yood RA, Edwards NL, Gutierrez-Urena SR, Treadwell EL, Vázquez-Mellado J, White WB, Lipsky PE, Horowitz Z, Huang W, Maroli AN, Waltrip RW 2nd, Hamburger SA, Becker MA. Sundy JS, et al. JAMA. 2011 Aug 17;306(7):711-20. doi: 10.1001/jama.2011.1169. JAMA. 2011. PMID: 21846852 Clinical Trial.
A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label study.
Botson JK, Tesser JRP, Bennett R, Kenney HM, Peloso PM, Obermeyer K, Song Y, LaMoreaux B, Zhao L, Xin Y, Chamberlain J, Ramanathan S, Weinblatt ME, Peterson J. Botson JK, et al. Arthritis Res Ther. 2022 Aug 25;24(1):208. doi: 10.1186/s13075-022-02865-z. Arthritis Res Ther. 2022. PMID: 36008814 Free PMC article.
Pegloticase for treating refractory chronic gout.
George RL Jr, Sundy JS. George RL Jr, et al. Drugs Today (Barc). 2012 Jul;48(7):441-9. doi: 10.1358/dot.2012.48.7.1813475. Drugs Today (Barc). 2012. PMID: 22844655 Review.
128 results